Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Flavonoid found in Epimedium.
FLT3, c-Kit, PDGFR inhibitor.
Taxol synthesis intermediate.
Sesquiterpene found in marine sponges.
Endogenous neuropeptide hormone, lowers extrace...
Benzophenanthridine alkaloid found in Garcinia....
p110γ PI3K inhibitor, potential TRPC1/5/6 nega...
Reversible DNMT1-selective inhibitor
Dipeptide; aminopeptidase (N/CD13) inhibitor.
Phytoestrogen, isoflavone found in various plan...
Non-steroid; AR antagonist.
Chaetocin is naturally produced by Chaetomium s...
β2-adrenergic agonist.
Mycotoxin produced by Fusarium fungi that infec...
Prenylflavinoid, derivative of xanthohumol foun...
Macrolide; protein synthesis inhibitor.
Cap-dependent endonuclease inhibitor
Mineralocorticoid, aldosterone, AR antagonist, ...
PLK1 inhibitor.
Methimazole prodrug; thyroid peroxidase inhibit...